CLNN
CLNN
NASDAQ · Biotechnology

Clene Inc

$4.06
-0.24 (-5.58%)
As of Sep 28, 10:29 PM ET ·
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Buy 10 91%
Hold 1 9%
Sell 0 0%
Price Target
Analyst Price Target +364.5% upside
Low Target $15.04
Average Target $18.86
High Target $28.67
Current Price $4.06
Current
$4.06
Target
$18.86
$15.04 $18.86 avg $28.67
Scenario Analysis
Bear Case
$15.04
270.4%
Low target
Base Case
$18.86
+364.5%
Avg target
Bull Case
$28.67
+606.2%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$13.50
-69.9% from high
52-Week Low
$3.25
+24.9% from low
Target vs 52W High
$18.86
+39.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -2.2%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.9%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +139.7%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.8%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -26.5%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.5%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -44.2%